Literature DB >> 32651936

The role played by traditional Chinese medicine in preventing and treating COVID-19 in China.

Qingwei Li1, Han Wang1,2, Xiuyang Li1, Yujiao Zheng1,3, Yu Wei1,3, Pei Zhang1, Qiyou Ding1,3, Jiaran Lin1,4, Shuang Tang1,4, Yikun Zhao5, Linhua Zhao6, Xiaolin Tong7.   

Abstract

Traditional Chinese medicine (TCM), an ancient system of alternative medicine, played an active role in the prevention and control of COVID-19 in China. It improved the clinical symptoms of patients, reduced the mortality rate, improved the recovery rate, and effectively relieved the operating pressure on the national medical system during critical conditions. In light of the current global pandemic, TCM-related measures might open up a new channel in the control of COVID-19 in other countries and regions. Here, we summarize the TCM-related measures that were widely used in China, including TCM guidelines, the Wuchang pattern, mobile cabin hospitals, integrated treatment of TCM and modern medicine for critical patients, and non-medicine therapy for convalescent patients, and describe how TCM effectively treated patients afflicted with the COVID-19. Effective TCM therapies could, therefore, be recommended and practiced based on the existing medical evidence from increased scientific studies.

Entities:  

Keywords:  COVID-19; Wuchang pattern; convalescent patients; mobile cabin hospital; three formulae and three medicines; traditional Chinese medicine

Mesh:

Substances:

Year:  2020        PMID: 32651936      PMCID: PMC7348116          DOI: 10.1007/s11684-020-0801-x

Source DB:  PubMed          Journal:  Front Med        ISSN: 2095-0217            Impact factor:   4.592


  7 in total

1.  [Mechanism of Xuanfei Baidu Tang in treatment of COVID-19 based on network pharmacology].

Authors:  Yi Wang; Xiang Li; Jun-Hua Zhang; Rui Xue; Jing-Yang Qian; Xiao-Hui Zhang; Han Zhang; Qing-Quan Liu; Xiao-Hui Fan; Yi-Yu Cheng; Bo-Li Zhang
Journal:  Zhongguo Zhong Yao Za Zhi       Date:  2020-05

Review 2.  Interpretation of the Traditional Chinese Medicine portion of the diagnosis and treatment protocol for corona virus disease 2019 (Trial Version 7).

Authors:  Ping Song; Linhua Zhao; Xiuyang Li; Jiansen Su; Zhaoyuan Jiang; Bin Song; Wenke Liu; Shuang Tang; Ye Lei; Qiyou Ding; Ze Yang; Jiaran Lin; Yu Wei; Xiaolin Tong
Journal:  J Tradit Chin Med       Date:  2020-06       Impact factor: 0.848

3.  Positive RT-PCR Test Results in Patients Recovered From COVID-19.

Authors:  Lan Lan; Dan Xu; Guangming Ye; Chen Xia; Shaokang Wang; Yirong Li; Haibo Xu
Journal:  JAMA       Date:  2020-04-21       Impact factor: 56.272

4.  Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial.

Authors:  Ke Hu; Wei-Jie Guan; Ying Bi; Wei Zhang; Lanjuan Li; Boli Zhang; Qingquan Liu; Yuanlin Song; Xingwang Li; Zhongping Duan; Qingshan Zheng; Zifeng Yang; Jingyi Liang; Mingfeng Han; Lianguo Ruan; Chaomin Wu; Yunting Zhang; Zhen-Hua Jia; Nan-Shan Zhong
Journal:  Phytomedicine       Date:  2020-05-16       Impact factor: 5.340

5.  XueBiJing Injection Versus Placebo for Critically Ill Patients With Severe Community-Acquired Pneumonia: A Randomized Controlled Trial.

Authors:  Yuanlin Song; Chen Yao; Yongming Yao; Hui Han; Xiaodong Zhao; Kaijiang Yu; Luyi Liu; Ying Xu; Zhongmin Liu; Qingshan Zhou; Ying Wang; Zhuang Ma; Youguang Zheng; Dawei Wu; Zhongzhi Tang; Minzhou Zhang; Shuming Pan; Yanfen Chai; Yan Song; Jian Zhang; Lei Pan; Yi Liu; He Yu; Xuezhong Yu; Hong Zhang; Xiaoge Wang; Zhaohui Du; Xianyao Wan; Yijun Tang; Yingping Tian; Yimin Zhu; Hongliang Wang; Xiaoyan Yan; Zhi Liu; Boli Zhang; Nanshan Zhong; Hongcai Shang; Chunxue Bai
Journal:  Crit Care Med       Date:  2019-09       Impact factor: 7.598

6.  Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2).

Authors:  Li Runfeng; Hou Yunlong; Huang Jicheng; Pan Weiqi; Ma Qinhai; Shi Yongxia; Li Chufang; Zhao Jin; Jia Zhenhua; Jiang Haiming; Zheng Kui; Huang Shuxiang; Dai Jun; Li Xiaobo; Hou Xiaotao; Wang Lin; Zhong Nanshan; Yang Zifeng
Journal:  Pharmacol Res       Date:  2020-03-20       Impact factor: 7.658

7.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors:  Zunyou Wu; Jennifer M McGoogan
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272

  7 in total
  18 in total

1.  Exploring the potential therapeutic effect of traditional Chinese medicine on coronavirus disease 2019 (COVID-19) through a combination of data mining and network pharmacology analysis.

Authors:  Xiuli Sun; Jinhe Jiang; Yang Wang; Shuying Liu
Journal:  Eur J Integr Med       Date:  2020-10-29       Impact factor: 1.314

2.  Analysis of the mechanism of Shufeng Jiedu capsule prevention and treatment for COVID-19 by network pharmacology tools.

Authors:  Haijun Xiong; Zhaowei Dong; Guanhua Lou; Qingxia Gan; Jin Wang; Qinwan Huang
Journal:  Eur J Integr Med       Date:  2020-10-30       Impact factor: 1.314

Review 3.  Research progress of traditional Chinese medicine against COVID-19.

Authors:  Wei Ren; Pan Liang; Yue Ma; Qin Sun; Qingrong Pu; Li Dong; Gang Luo; Maryam Mazhar; Jiali Liu; Raoqiong Wang; Sijin Yang
Journal:  Biomed Pharmacother       Date:  2021-02-03       Impact factor: 7.419

Review 4.  Fever and Antipyretic Supported by Traditional Chinese Medicine: A Multi-Pathway Regulation.

Authors:  Le-Le Ma; Hui-Min Liu; Chuan-Hong Luo; Ya-Nan He; Fang Wang; Hao-Zhou Huang; Li Han; Ming Yang; Run-Chun Xu; Ding-Kun Zhang
Journal:  Front Pharmacol       Date:  2021-03-22       Impact factor: 5.810

Review 5.  Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: Efficacies and mechanisms.

Authors:  Kai Huang; Pan Zhang; Zhenghao Zhang; Ji Youn Youn; Chen Wang; Hongchun Zhang; Hua Cai
Journal:  Pharmacol Ther       Date:  2021-03-31       Impact factor: 13.400

6.  Impact of the COVID-19 pandemic on intention to use traditional Chinese medicine: A cross-sectional study based on the theory of planned behavior.

Authors:  Yi Xia; Lu-Shao-Bo Shi; Jing-Hui Chang; Hua-Zhang Miao; Dong Wang
Journal:  J Integr Med       Date:  2021-01-22

Review 7.  Yunpi Qufeng Chushi Formula for Pre-Rheumatoid Arthritis: Study Protocol for a Multiple-Center, Double-Blind, Placebo-Controlled Randomized Controlled Trial.

Authors:  Yujun Tang; Haichang Li; Lin Huang; Qiao Wang; Yongmei Han; Huaxiang Wu; Xiao Su; Xiujuan Hou; Chuanbing Huang; Changsong Lin; Qingwen Tao; Jinyang Tang; Wei Cao; Zhijun Xie; Chengping Wen
Journal:  Front Pharmacol       Date:  2022-02-14       Impact factor: 5.810

8.  Ludangshen oral liquid for treatment of convalescent COVID-19 patients: a randomized, double-blind, placebo-controlled multicenter trial.

Authors:  Xuedong An; Bo Peng; Xiaodong Huang; Hongmei Jiang; Zhang'e Xiong; Hong Zhang; Fengmei Lian; Yuanming Ba; Xiaolin Tong
Journal:  Chin Med       Date:  2022-04-02       Impact factor: 5.455

Review 9.  Immunomodulation for Severe COVID-19 Pneumonia: The State of the Art.

Authors:  Yinhua Zhang; Yuanyuan Chen; Zhongji Meng
Journal:  Front Immunol       Date:  2020-11-09       Impact factor: 8.786

Review 10.  Application of Big Data and Artificial Intelligence in COVID-19 Prevention, Diagnosis, Treatment and Management Decisions in China.

Authors:  Jiancheng Dong; Huiqun Wu; Dong Zhou; Kaixiang Li; Yuanpeng Zhang; Hanzhen Ji; Zhuang Tong; Shuai Lou; Zhangsuo Liu
Journal:  J Med Syst       Date:  2021-07-24       Impact factor: 4.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.